What Does an IGF-1 Test For? Reading Your Growth Hormone Marker

Insulin-like Growth Factor 1, a protein released by the liver, offers a long-lasting snapshot of growth hormone activity throughout the day. Because growth hormone itself pulses every few hours, a single random GH read can mislead; IGF-1 stays roughly constant through the day. That’s why clinicians lean on it for screening kids with growth concerns and adults whose symptoms point toward a GH imbalance, from acromegaly to deficiency.

What follows covers what the marker actually does, when a clinician orders it, and how to read the result alongside your age and sex.

IGF-1 as a Window Into Growth Hormone Activity

Insulin-like Growth Factor 1, often written IGF-1 and formerly called somatomedin C, is a small protein made mostly by the liver. Your pituitary releases growth hormone in sharp pulses, mainly at night and after exercise, and those pulses land on liver cells. Once switched on, the liver releases IGF-1, which circulates bound to IGF-binding proteins and travels to bone, muscle, cartilage, and most other tissues.

There it drives cell proliferation, bone growth, and a long list of metabolic maintenance jobs that GH started but cannot finish on its own. The whole chain is often called the GH–IGF-1 axis, and it runs from the brain to the liver and back out to your tissues.

The half-life of IGF-1 is roughly 15 to 18 hours, so the number on your report integrates GH pulses over the previous day. A random GH draw, by contrast, can catch a pulse at almost any level, which is why GH alone makes a poor screening tool.

Why That Stability Matters for Screening

When your provider suspects GH excess or deficiency, they want one number that reflects your average GH environment, not a snapshot of the last nap or snack. IGF-1 gives them that. A random GH level can look falsely low at 10 a.m. or falsely high after a stressful meeting; IGF-1 will read the same in both cases.

That stability is the single biggest reason IGF-1 has become the first-line blood marker in endocrine evaluation. It survives fasting, sleep cycles, and minor stress without moving much, so a single draw becomes a reliable read.

That stability is precisely why clinicians reach for it first when growth hormone activity needs clarifying.

Why Doctors Order IGF-1 Levels

Clinicians reach for this test when the picture points toward the GH–IGF-1 axis behaving abnormally. Three broad situations drive most orders: a child whose height curve is bending off the chart, an adult whose features are slowly enlarging, and a patient whose pituitary function needs a post-treatment check.

Screening for Excess GH in Adults and Children

A 47-year-old whose rings no longer fit, whose jaw feels heavier in photos, and whose dentist just asked about a tongue bite during sleep is a textbook candidate. In adults, persistently elevated IGF-1 paired with these symptoms raises suspicion for acromegaly, almost always caused by a GH-secreting pituitary adenoma. In children, the same hormonal excess produces gigantism: rapid linear growth far above the 97th percentile, coarse features, and early joint pain.

In both groups, IGF-1 is the screening lab that pulls the case into view. Without it, the slow changes of acromegaly can go unrecognized for a decade.

Evaluating GH Deficiency at Any Age

On the other end of the spectrum, a child whose height percentile has dropped two lines in three years, or an adult whose muscle mass has melted away alongside stubborn fatigue and central weight gain, may have GH deficiency. IGF-1 is ordered first because, again, it averages the GH environment.

Low or low-normal results in someone with the right symptoms prompt follow-up dynamic testing rather than a treatment decision made on a single number. A one-off draw is never enough to start replacement therapy.

Monitoring Pituitary and Systemic Disease

Surveillance after pituitary surgery, radiation, or treatment for a known adenoma is a third common reason. IGF-1 is drawn at regular intervals because recurrence shows up in the marker long before you feel anything new.

Outside the pituitary, chronic liver disease and chronic kidney disease can suppress IGF-1 production or alter its binding proteins. Hepatologists and nephrologists use the assay to gauge how much apparent GH axis suppression is coming from the liver or kidneys rather than the pituitary itself.

How the Test Is Performed and What Preparation Looks Like

Getting IGF-1 measured is no more involved than a routine blood draw. A phlebotomist wraps a tourniquet, fills one or two tubes from a vein in your arm, and you’re done. Most people are out of the lab in under five minutes.

The sample is spun down into serum and run on an automated immunoassay platform, the same kind used by reference labs such as LabCorp and Quest Diagnostics for routine hormone panels. Results usually come back in one to three business days.

Pre-Test Preparation in Plain Terms

Most providers will ask you to fast overnight and arrive in a rested state. IGF-1 itself is not strongly affected by a recent meal, the way glucose or triglycerides are, but fasting keeps the rest of the panel clean and removes one more source of variability.

Skip intense exercise the morning of the draw, since vigorous activity can shift IGF-binding protein levels. Continue any prescribed medications unless your clinician tells you otherwise, and bring a list of supplements, oral estrogens, or anabolic agents, because some of these alter the result.

Your provider will want that context before reading the number, not after.

Practical tip: schedule the draw for early morning, before your first coffee, and treat the appointment like a fasting lab visit. The number on the report will more accurately reflect your baseline.

Why IGFBP-3 Often Travels Alongside IGF-1

Most of the IGF-1 in circulation is bound to IGF-binding protein 3, and that binding controls how much free IGF-1 is available to tissues. Drawing both analytes at once gives the clinician a paired read: IGF-1 tells the headline story, while IGFBP-3 adds diagnostic weight when the result is borderline.

In children, binding-protein levels naturally differ from adults, so the pair helps separate true GH axis problems from developmental variation.

Reading IGF-1 Results Against Age and Sex Norms

There’s no universal “normal” IGF-1 number the way there is for sodium or hemoglobin. Reference ranges are calculated separately for each age band and for males versus females, because circulating IGF-1 rises during puberty, plateaus in young adulthood, and declines gradually afterward.

A level that’s perfectly healthy for a 14-year-old would look low for a 30-year-old and high for a 75-year-old. Always read your value against the printed interval on your report, never against a number you remember from a previous decade.

What High Results Typically Suggest

Persistently elevated IGF-1 in an adult with enlarged hands, deepening voice, joint pain, sleep apnea, or visual changes points toward acromegaly. In a child with rapid linear growth, the same elevation suggests gigantism.

In either case, the next step is almost always a pituitary MRI to look for an adenoma, paired with an oral glucose suppression test. In a healthy person, a 75-gram glucose load suppresses GH to below 1 ng/mL, while in acromegaly GH fails to suppress.

What Low Results Typically Suggest

Reduced IGF-1 in a slow-growing child often points to GH deficiency, especially when bone age is delayed on hand X-ray. In adults, the differential widens: pituitary insufficiency, Laron syndrome, chronic liver disease, malnutrition, and uncontrolled diabetes can all drag IGF-1 downward.

Laron syndrome is a rare GH receptor resistance in which the body cannot respond to the GH it makes. A single low value is rarely treated on its own; it almost always triggers repeat testing, dynamic stimulation testing, or imaging before any decision is made.

This cautious sequencing is exactly why many clinicians pair it with a direct measurement rather than rely on either alone.

Result RangeMost Common CausesTypical Next Step
High, age-adjustedAcromegaly, gigantism, GH-secreting pituitary adenomaPituitary MRI, oral glucose suppression test
Low, age-adjustedGH deficiency, Laron syndrome, chronic liver disease, malnutritionRepeat IGF-1, GH stimulation test, pituitary MRI
Borderline or discordant with symptomsEarly disease, binding protein shift, medication effectIGFBP-3, dynamic GH testing, specialist review

IGF-1 Versus a Direct Growth Hormone Test

A direct GH measurement sounds like the obvious choice, and patients often expect it. In practice, a random GH is one of the least reliable hormone tests on a standard panel, because GH pulses every 90 to 120 minutes, spikes during slow-wave sleep, rises with stress and exercise, and falls between pulses.

Two draws from the same patient on the same day can differ by a factor of five. That’s a problem when you’re trying to make a diagnosis on a single number.

Why Dynamic GH Testing Exists

When the IGF-1 result is borderline or doesn’t match the clinical picture, endocrinologists turn to stimulation and suppression tests. A stimulation test (insulin-induced hypoglycemia, glucagon, or macimorelin) tries to provoke GH release; a healthy axis responds robustly, while GH deficiency shows a blunted peak.

A suppression test, almost always the oral glucose tolerance test for GH, asks whether a glucose load can turn GH off. These tests are more involved, more expensive, and harder on the patient, which is exactly why IGF-1 is ordered first.

The Practical Workflow

  1. Screen with IGF-1. One fasting blood draw, read against your age and sex reference range.
  2. Confirm with dynamic studies. Only when step one is abnormal or clinically ambiguous does an endocrinologist order a stimulation or suppression test.
  3. Image the pituitary. Only when the dynamic study confirms the suspicion does pituitary MRI enter the picture.

That sequencing keeps you from undergoing glucose loads and provocative testing you don’t need.

Special Uses, Limits, and Smart Next Steps

Outside the clinic, IGF-1 shows up in sports medicine and anti-doping programs. The Athlete Biological Passport uses IGF-1 alongside other markers under the GH-2000 score to flag recombinant GH misuse over time. Serial measurements catch ratios that drift in a pattern consistent with doping.

The same biomarker that diagnoses acromegaly in a 50-year-old can catch cheating in a 25-year-old athlete. The assay works in both worlds because the underlying biology of GH excess is the same.

Confounders Worth Knowing

Several common factors can shift your IGF-1 independent of true GH status:

  • Oral estrogen raises IGF-binding protein-1 and can lower measured IGF-1.
  • Pregnancy and severe illness shift multiple binding proteins at once.
  • Thyroid disease, particularly untreated hypothyroidism, can nudge the number downward.
  • Uncontrolled diabetes and chronic glucocorticoid use each alter IGF-1 production.

None of these makes the test useless, but each is a reason your provider will interpret the result in context rather than in isolation.

Warning: a single IGF-1 outside the reference range is a starting point, not a verdict. Repeat testing, dynamic GH studies, and pituitary imaging usually need to follow before anyone diagnoses acromegaly, gigantism, or GH deficiency.

What to Do With Your Result

Bring the actual report to an endocrinologist rather than relying on the patient portal summary, because the age- and sex-adjusted percentile matters as much as the headline number. Ask whether the result fits your symptoms and exam findings.

If it’s borderline, request a repeat draw before any imaging, since lab drift between runs is real. If it’s clearly abnormal, ask about IGFBP-3, dynamic GH testing, and pituitary MRI in that order, and expect the workup to take weeks rather than days.

For children, pediatric endocrinology is the right specialty from the start; for adults, a general endocrinologist handles the initial workup and refers onward if a pituitary tumor is found.

Knowing who to call first can shorten the path from an abnormal number to a clear plan.

Final Thoughts

IGF-1 is the most useful single blood marker your provider has for gauging growth hormone activity, precisely because it doesn’t behave like growth hormone. One fasting morning draw, read against your age and sex norms, can screen for acromegaly, gigantism, and GH deficiency before any imaging or provocative testing is on the table.

Treat the result as a screening tool, repeat it when it’s borderline, and let an endocrinologist drive the next step. The endocrine system runs on feedback loops, and IGF-1 gives you the cleanest single snapshot of where those loops are set.

FAQ

What does an IGF-1 test for?

Insulin-like Growth Factor 1 circulates in the bloodstream and mirrors the body’s average growth hormone output over many hours. Because IGF-1 stays roughly constant through the day, it gives clinicians a reliable read on your average GH environment to help diagnose conditions like acromegaly, gigantism, and growth hormone deficiency.

Why would a doctor order an IGF-1 test?

Most often because symptoms or growth patterns suggest the GH–IGF-1 axis is over- or under-active. In adults, this includes enlarged hands and feet, jaw growth, joint pain, fatigue, or unexplained changes in body composition. In children, it’s ordered when height or growth velocity falls off the standard curve.

What conditions does an IGF-1 test help diagnose?

Elevated IGF-1 can point toward acromegaly, gigantism, or a GH-secreting pituitary adenoma. Low IGF-1 may suggest GH deficiency, Laron syndrome (a rare GH receptor resistance), chronic liver disease, or malnutrition. Borderline results usually lead to repeat testing or dynamic GH studies.

Is IGF-1 the same as growth hormone?

No. IGF-1 is a separate hormone produced mostly by the liver in response to growth hormone. GH pulses through the day, while IGF-1 stays steady, which is why IGF-1 is the practical screening marker and direct GH is reserved for dynamic testing.

How do I interpret my IGF-1 results?

Always read IGF-1 against the age- and sex-specific reference range on your report, not a single universal number. Results are typically reported as a value, a reference interval, and sometimes a Z-score or standard deviation score. Interpretation depends on whether the value is high, low, or borderline, and whether it matches your symptoms.

Do children need IGF-1 testing?

Yes, often. Pediatricians and pediatric endocrinologists order IGF-1 when a child’s growth curve flattens or accelerates unexpectedly, when there’s a large gap between the child’s height and the family pattern, or when puberty is delayed or premature. The same age-adjusted reference logic applies, with pediatric norms built into the assay report.

Staff
Staff

Our team brings together health and food enthusiasts who are passionate about discovering reliable health information, nutritious choices, and enjoyable food experiences. From everyday nutrition and healthy eating ideas to recipes, ingredients, food trends, and standout dishes, we share carefully researched and thoughtfully curated content to help readers make informed choices about what they eat and enjoy.